http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2762249-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18 |
| filingDate | 2012-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd650f0cd96e700e377bd4a0be6df5ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84b84484ae1f04f08763da317ce876b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b88930ef2d100bcea1cb365c3597703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92e06362e3c3ee9d4c5a069fa3fcf2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0ae405312853419bc87b4cc0d48d195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ef468836bceb4c80ce0e58b63223ae8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d1c587c80313690da05a895531c5bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_979f883223c8c0598503d155b6f92b9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a419de45ad107e7f8435010f20ad153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73b2334d6dd81a1180bdba81b573eaf8 |
| publicationDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2762249-T3 |
| titleOfInvention | Use of aryl- and hetarylcarboxamides as endoparasiticides |
| abstract | Compounds according to formula (I) ** Formula ** in which X represents phenyl, thienyl or furanyl substituted one or more times with M1; Q represents pyridyl, thienyl, furanyl or isothiazolyl substituted one or more times with M1; Y represents hydrogen or (C1-C10) alkyl, (C2-C10) alkenyl, (C2-C10) alkynyl, (C1-C10) haloalkyl, (C2-C10) haloalkenyl, (C2-C10) haloalkynyl, (C1-C10) alkoxy C10), alkenyl (C2-C10) -oxy, alkynyl (C3-C10) -oxy, cycloalkyl (C3-C14) -alkyl (C1-C10) optionally substituted one or more times with M2 or represents a cyclic group from 3 to 14 members optionally substituted one or more times with M2; W represents oxygen or sulfur; L1 represents -C (R11, R12) -, oxygen, sulfur or -N (R1) -; L2 represents -C (R21, R22) -; L3 represents -C (R31, R32) - or a direct bond; M1 represents hydrogen, halogen, cyano, nitro, OH, (C1-C10) alkyl, (C1-C10) haloalkyl, (C1-C10) alkoxy, (C1-C10) haloalkoxy, (C1-C10) alkylthio, haloalkyl (C1-C10) -thio, (C1-C10) alkyl-sulfonyl, (C1-C10) haloalkyl-sulfonyl, (C1-C10) alkyl-sulfanyl, (C1-C10) haloalkyl-sulfanyl, (cyclic group from 3 to 14 members) -O-; R1 represents hydrogen or (C1-C10) alkyl, (C2-C10) alkenyl, (C2-C10) alkynyl, (C1-C10) haloalkyl, (C2-C10) haloalkenyl, (C2-C10) haloalkynyl, (C3-cycloalkyl) C10)-(C1-C10) alkyl optionally substituted one or more times with M2 or represents a 3- to 14-membered cyclic group optionally substituted one or more times with M2; R11, R12 represent in each case independently of one another hydrogen, halogen or (C1-C10) alkyl, (C2-C10) alkenyl, (C2-C10) alkynyl, (C1-C10) haloalkyl, (C2-C10) haloalkenyl, haloalkynyl (C2-C10), alkoxy (C1-C10), alkenyl (C2-C10) -oxy, alkynyl (C3-C10) -oxy, cycloalkyl (C3-C14) -alkyl (C1-C10) optionally substituted one or more times with M2 or represents a 3- to 14-membered cyclic group optionally substituted one or more times with M2; R11, R12 together represent a 3- to 14-membered carbocyclic or 3- to 10-membered heterocyclic group spiro-linked in each case and optionally substituted one or more times with M2; R21, R22 represent in each case, independently of each other, hydrogen, halogen or (C1-C10) alkyl, (C2-C10) alkenyl, (C2-C10) alkynyl, (C1-C10) haloalkyl, (C2-C10) haloalkenyl ), haloalkynyl (C2-C10), alkoxy (C1-C10), haloalkoxy (C1-C10), alkenyl (C2-C10) -oxy, alkynyl (C3-C10) -oxy, cycloalkyl (C3-C14) -alkyl ( C1-C10) optionally substituted one or more times with M2 or represents a 3- to 14-membered cyclic group optionally substituted one or more times with M2; R21, R22 together represent a 3- to 14-membered carbocyclic or 3- to 10-membered heterocyclic group spiro-linked in each case and optionally substituted one or more times with M2; R31, R32 represent in each case, independently of one another, hydrogen or (C1-C10) alkyl, (C2-C10) alkenyl, (C2-C10) alkynyl, (C1-C10) haloalkyl, (C2-C10) haloalkenyl, (C2-C10) haloalkynyl, (C3-C14) cycloalkyl (C1-C10) alkyl optionally substituted one or more times with M2 or represents a cyclic group from 3 to 14 membered optionally substituted one or more times with M2; R31, R32 together represent a 3- to 14-membered carbocyclic or 3- to 10-membered heterocyclic group spiro-bound in each case and optionally substituted one or more times with M2; M2 represents in each case, independently of one another, halogen, formyl, cyano, nitro, (C1-C10) alkyl, (C1-C10) haloalkyl, (C2-C10) alkenyl, (C2-C10) haloalkenyl, (C2) alkynyl -C10), haloalkynyl (C2-C10), alkoxy (C1-C10), haloalkoxy (C1-C10), alkenyl (C2-C10) -oxy, haloalkenyl (C2-C10) -oxy, alkynyl (C3-C10) - oxy, haloalkynyl (C3-C10) -oxy, (C1-C10) alkylthio, halo (C1-C10) -thio, alkenyl (C2-C10) -thio, haloalkenyl (C2-C10) -thio, alkynyl (C3) -C10) -thio, halo (C3-C10) -thio, (C1-C10) alkyl-sulfonyl, halo (C1-C10) -sulfonyl, alkenyl (C2-C10) -sulfonyl, haloalkenyl (C2-C10) -sulfonyl , (C3-C10) alkynyl, haloalkynyl (C3-C10) -sulfonyl, (C1-C10) alkyl-sulfanyl, halo (C1-C10) -sulfanyl, alkenyl (C2-C10) -sulfanyl, haloalkenyl (C2- C10) -sulfanyl, alkynyl (C3-C10) -sulfanyl, haloalkynyl (C3-C10) -sulfanyl, alkyl (C1-C10) -carbonyl, haloalkyl (C1-C10) -carbonyl, alkenyl (C2-C10) -carbonyl, haloalkenyl (C2-C10) -carbonyl, alkynyl (C2-C10) -carbonyl, haloalkynyl (C2-C10) -carbonyl, (C1-C10) alkoxy -carbonyl, (C1-C10) haloalkoxy -carbonyl, (C2-C10) alkenoxy, (C2-C10) haloalkenoxy -carbonyl, (C3-C10) alkynoxy, haloalkynoxy (C3-C10) -carbonyl, (C1-C10) alkylcarbonyloxy, halo (C1-C10) -carbonyloxy, alkenyl (C2-C10) -carbonyloxy, haloalkenyl ( C2-C10) -carbonyloxy, alkynyl (C2-C10) -carbonyloxy, haloalkynyl (C2-C10) -carbonyloxy, 3-14 membered cyclic group; and their salts, N-oxides and tautomeric forms; for use as drugs to combat endoparasites in animals or humans. |
| priorityDate | 2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 248.